Hypothyroidism and its associated factors after radioactive iodine therapy among patients with hyperthyroidism in the Northeast Coast State of Malaysia

Abstract

Objectives The aim of this study was to determine the incidence of hypothyroidism and its associated factors within one-year post radioactive iodine (RAI) therapy. Methods A retrospective study was conducted among patients with hyperthyroidism who received RAI therapy at Nuclear Medicine Clinic, Hospital Universiti Sains Malaysia (HUSM), Kelantan. Data regarding patients’ demographics, gender, aetiology of hyperthyroidism, presence of autoantibodies, dose of RAI used and usage of antithyroid drug post RAI therapy were included in the analysis. Results Of a total of 167 screened patients, 137 subjects were eligible for this study. The incidence of hypothyroidism within one year of RAI therapy was 32.9%. Women were found to be less likely to develop hypothyroidism post RAI therapy (adjusted odds ratio, 0.406; 95% confidence interval: 0.181–0.908; p = 0.028). The usage of antithyroid drug post RAI was significantly associated with a lower incidence of hypothyroidism post RAI therapy (adjusted odds ratio, 0.188; 95% confidence interval: 0.081–0.438; p <0.001). Conclusion This study showed a high incidence of hypothyroidism within one-year post RAI therapy. Gender and usage of antithyroid drug post RAI therapy are significantly associated with the development of hypothyroidism.

Predictive factors for early hypothyroidism following the radioactive iodine therapy in Graves’ disease patients

“…The subsequent logistic regression analysis also suggested that male gender was a risk factor of early hypothyroidism even accounting for other clinical factors. This is quite different with the previous studies, but we found recently a research of Malaysia also prompt that men became to hypothyroid easier than women [28]. We hypothesized that the difference may be because the genetic susceptibility among different races.…”

Radiation Induced Hypothyroidism an Underestimated Entity-Observational Study

“…Within one year nearly 33% and by 10-and 25-year post RAI, 59%-82% developed HT. 22 While in non-immunogenic hyperthyroidism (nodules, goitre) RAI results in lower incidence of RIHT 4% after 1 year, 15% after 10 years, and 32% after 25 years. Unlike RIHT for HNC treatment in which females were at higher risk, women treated with I-131 were less likely to develop HT.…”

Radioiodine therapy outcome in toxic multinodular goiter patient with concomitant hereditary Hasharon hemoglobinopathy

“…Эмпирический опыт, накопленный в результате применения РЙТ в разных возрастных группах в течение 80 лет, свидетельствует в пользу эффективности данного вида лечения, в том числе при лечении гипертиреоза. В большинстве случаев достичь стойкого гипотиреоза удается в течение 6-12 месяцев после лечения радиоактивным йодом [8][9][10]. Преимуществами РЙТ являются минимальные ограничения метода даже при наличии сопутствующих заболеваний и возможность неоднократного проведения.…”